References
- Cao J, Zheng L, Ji L, et al. (2015). Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin. Chem Biol Interact 226:23–9
- Faucette SR, Hawke RL, Lecluyse EL, et al. (2000). Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos 28:1222–30
- Huang Z, Roy P, Waxman DJ. (2000a). Role of human microsomal CYP3A4 and CYP2B6 in catalyzing N-dechlorethylation of cyclophosphamide and ifosfamide. Biochem Pharmacol 59:961–72
- Huang J, Zhao L, Zou Q, et al. (2000b). New developments of chemical and pharmacological study on psoralea corylifolia. Prog Pharm Sci 24:212–14
- Kang AY, Young LR, Dingfelder C, et al. (2011). Effects of furanocoumarins from apiaceous vegetables on the catalytic activity of recombinant human cytochrome P450 1A2. Protein J 30:447–56
- Kent UM, Jushchyshyn MI, Hollenberg PF. (2001). Mechanism-based inactivators as probes of cytochrome P450 structure and function. Curr Drug Metab 2:215–43
- Kent LK, William FT. (1993). Isoform selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem Res Tonicol 6:649–56
- Klaassen CD, Amdur MO, Doull J. (1986). Biotransformation of xenobiotics. In: Klaassen CD, ed. Casarett and Doull’s Toxicology, the basic science of poisons. New York: McGraw-Hill, 113–86
- Koenigs LL, Trager WF. (1998a). Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochem 37:10047–61
- Koenigs LL, Trager WF. (1998b). Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins. Biochem 37:13184–93
- Lin HL, Kenaan C, Hollenberg PF. (2012). Identification of the residue in human CYP3A4 that is covalently modified by bergamottin and the reactive intermediate that contributes to the grapefruit juice effect. Drug Metab Dispos 40:998–1006
- Lin HL, Kent UM, Hollenberg PF. (2005). The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5. J Pharmacol Exp Ther 313:154–64
- Lin G, Tang J, Liu X, et al. (2007). Deacetylclivorine:A gender-selective metabolite of clivorine formed in female SD rat liver microsome. Drug Metab Dispos 35:607–13
- Lv J, Lin D, Li Z. (1996). New developments of chemical and pharmacological study on psoralea corylifolia. J Shenyang Pharm Univ 13:220–3
- Miksys S, Lerman C, Shields PG, et al. (2003). Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology 45:122–32
- Nadine BC, Delporte CL, Negrete RE, et al. (2001). Active constituents isolated from Psoralea glandulosa L. with antiinflammatory and antipyretic activities. J Ethnopharmacol 78:27–31
- Qiu R, Li L, Le W. (2010). New developments of chemical and pharmacological study on Psoralea corylifolia. J Chin Med Mater 33:1656–9
- Schmiedlin RP, Edwards DJ, Fitzsimmons ME, et al. (1997). Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 25:1228–33
- Sridar C, Kenaan C, Hollenberg PF. (2012). Inhibition of bupropion metabolism by selegiline:mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts. Drug Metab Dispos 40:2256–66
- Stresser DM, Kupfer D. (1999). Monospecific antipeptide antibody to cytochrome P450 2B6. Drug Metab Dispos 27:517–25
- Tang L, Zhang S, Chen X. (2011). Determination of psoralen and isopsoralen in psoralea from different sources by HPLC. China Pharm 14:377–8
- Ward BA, Gorski JC, Jones DR, et al. (2003). The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther 30:287–300
- Zhao P, Niu J, Wang J, et al. (2009). Estrogen effect and mechanism of isopsoralen contained Psoralea corylifolia. Chin Pharmacol Bull 25:1193–7
- Zheng L, Cao J, Lu D, et al. (2015). Imperatorin is a mechanism-based inactivator of CYP2B6. Drug Metab Dispos 43:82–8
- Zhuang X, Zhong Y, Xiao W, et al. (2013). Identification and characterization of psoralen and isopsoralen as potent CYP1A2 reversible and time-dependent inhibitors in human and rat preclinical studies. Drug Metab Dispos 43:82–8